Career Enhancement Program
Career Enhancement Program
批准号:
10208782
负责人:
Jon C.D. Houtman
金额:
$7.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-11 至 2023-06-30
关键词:
AreaAwardBioinformaticsCareer ChoiceClinicClinicalClinical InvestigatorCollaborationsDevelopmentFacultyFinancial SupportFoundationsFundingGoalsGroup MeetingsHumanIndividualInfrastructureInstitutionInterdisciplinary StudyIowaLymphomaMalignant NeoplasmsMalignant lymphoid neoplasmMentorsMentorshipMinorityPeer ReviewPostdoctoral FellowProcessProductivityResearchResearch PersonnelResearch ProposalsResearch TrainingResourcesRoleScientistSeriesSiteSpecialized Program of Research ExcellenceSystemTrainingTraining ActivityUnderrepresented MinorityUniversitiesWomanYangbasecandidate selectioncareercareer developmentexperienceinterestmeetingsmultidisciplinarypopulation basedprogramssuccesstranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT: Career Enhancement Program (CEP). The goal of the University of Iowa/Mayo Clinic
Lymphoma SPORE (SPORE) Career Enhancement Program (CEP) is to provide support (both financial
support and extensive mentorship) to highly promising, well-trained scientists interested in pursuing a career in
translational lymphoma research. The CEP allows for the support each year of two highly promising
investigators who are engaged in SPORE research. The extensive research and training base available at
these two institutions as well as the infrastructure of the SPORE provides an outstanding foundation for the
SPORE CEP. Successful candidates for the SPORE CEP are typically young investigators (senior postdoctoral
fellows about to begin their faculty careers, and young faculty) in translational, multidisciplinary basic, clinical or
population-based lymphoma research. On occasion, the CEP is used to assist more experienced, successful
investigators interested in shifting their research focus toward translational lymphoma research. The SPORE
CEP provides $50,000 for one year ($25,000 from SPORE funds and institutional support of $25,000 from the
University of Iowa or Mayo Clinic resources) for each of two awards per year. A second year of support is
possible based on progress and successful re-competition. During this most recent funding period (years 11-
15), 10 investigators, including two under-represented minority faculty and four women, received CEP awards
and were each supported for 1 year. They all remain active translational investigators in the field of lymphoid
malignancies with 9 of the 10 still involved with the SPORE and the 10th a successful investigator at another
institution. The CEP awardee (Gupta) from a previous funding period was a co-leader on the current Project 3.
In this renewal application, another CEP awardee (Feldman) has become Project 1 co-leader and also Director
of the Biospecimens Core. The research of Dr. Z. Yang was important to the proposed Project 1 and Dr.
Asmann's research has led to her role in the Biospecimens and Bioinformatics Core in this renewal. During the
next funding period, the SPORE will maintain: (1) a stringent candidate selection system that encourages
applications from minorities and women; (2) comprehensive trainee guidance by a mentor; (3) support through
a scientific mentor group (the Individual Trainee Mentorship Committee) comprised of investigators with
expertise in each trainee's area of interest; (4) multi-disciplinary research courses and on-going training
activities such as the Multidisciplinary Cancer Seminar Series and Lymphoma Group meetings at both sites;
(5) encouragement of collaboration with investigator group meetings at both sites; (6) encouragement of
collaboration with investigators at both Iowa and Mayo and (7) opportunities for further research enhancement
through the Developmental Research Program and full Projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
R25 YES: Cancer Research Opportunities at Iowa
-
批准号:10712349
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2023
-
负责人:Jon C.D. Houtman
-
依托单位:
MMP-9 based immune-driven mechanisms of neovascular AMD
-
批准号:10719958
-
项目类别:
-
资助金额:$54.04万
-
财政年份:2023
-
负责人:Jon C.D. Houtman
-
依托单位:
CD4 T cell intrinsic signaling defects during viral exhaustion
-
批准号:10359809
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2021
-
负责人:Jon C.D. Houtman
-
依托单位:
Cooperative SH2 and SH3 domain-mediated interactions at the adaptor protein Grb2
-
批准号:8220881
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2010
-
负责人:Jon C.D. Houtman
-
依托单位:
Cooperative SH2 and SH3 domain-mediated interactions at the adaptor protein Grb2
-
批准号:8530594
-
项目类别:
-
资助金额:$3.79万
-
财政年份:2010
-
负责人:Jon C.D. Houtman
-
依托单位:
Cooperative SH2 and SH3 domain-mediated interactions at the adaptor protein Grb2
-
批准号:8795270
-
项目类别:
-
资助金额:$5.47万
-
财政年份:2010
-
负责人:Jon C.D. Houtman
-
依托单位:
Cooperative SH2 and SH3 domain-mediated interactions at the adaptor protein Grb2
-
批准号:8606956
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2010
-
负责人:Jon C.D. Houtman
-
依托单位:
Cooperative SH2 and SH3 domain-mediated interactions at the adaptor protein Grb2
-
批准号:8610251
-
项目类别:
-
资助金额:$29.48万
-
财政年份:2010
-
负责人:Jon C.D. Houtman
-
依托单位:
Cooperative SH2 and SH3 domain-mediated interactions at the adaptor protein Grb2
-
批准号:7883144
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2010
-
负责人:Jon C.D. Houtman
-
依托单位:
Cooperative SH2 and SH3 domain-mediated interactions at the adaptor protein Grb2
-
批准号:8068032
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2010
-
负责人:Jon C.D. Houtman
-
依托单位:
Cooperative SH2 and SH3 domain-mediated interactions at the adaptor protein Grb2
-
批准号:8447598
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2010
-
负责人:Jon C.D. Houtman
-
依托单位:
Career Enhancement
-
批准号:10600127
-
项目类别:
-
资助金额:$5.41万
-
财政年份:2000
-
负责人:Jon C.D. Houtman
-
依托单位:
Career Enhancement
-
批准号:10395518
-
项目类别:
-
资助金额:$5.41万
-
财政年份:2000
-
负责人:Jon C.D. Houtman
-
依托单位:
海外基金